Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease

Metab Brain Dis. 2015 Dec;30(6):1395-400. doi: 10.1007/s11011-015-9711-z. Epub 2015 Aug 4.

Abstract

Intermittent maple syrup urine disease (MSUD) is a potentially life-threatening metabolic disorder caused by a deficiency of branched chain α-ketoacid dehydrogenase (BCKD) complex. In contrast to classic MSUD, children with the intermittent form usually have an atypical clinical manifestation. Here, we describe the presenting symptoms and clinical course of a Chinese boy with intermittent MSUD. Mutation analysis identified two previously unreported mutations in exon 7 of the BCKDHB gene: c.767A > G (p.Y256C) and c.768C > G (p.Y256X); the parents were each heterozygous for one of these mutations. In silico analysis predicted Y256C probably affects protein structure; Y256X leads to a premature stop codon. This case demonstrates intermittent MSUD should be suspected in cases with symptoms of recurrent encephalopathy, especially ataxia or marked drowsiness, which usually present after the neonatal period and in conjunction with infection. symmetrical basal ganglia damage but normal myelination in the posterior limb will assist differential diagnosis; alloisoleucine is a useful diagnostic marker and mutation analysis may be of prognostic value. These novel mutations Y256C and Y256X result in the clinical manifestation of a variant form of MSUD, expanding the mutation spectrum of this disease.

Keywords: BCKDHB gene; Maple syrup urine disease; Mutation; Variant form.

Publication types

  • Case Reports

MeSH terms

  • 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) / genetics*
  • Amino Acid Substitution
  • Basal Ganglia / pathology
  • Brain / pathology
  • Codon / genetics
  • Computer Simulation
  • Diffusion Magnetic Resonance Imaging
  • Exons / genetics
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Maple Syrup Urine Disease / genetics*
  • Maple Syrup Urine Disease / pathology
  • Molecular Sequence Data
  • Mutation / genetics
  • Myelin Sheath / pathology
  • Prognosis

Substances

  • Codon
  • 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)